Previous close | 1.8600 |
Open | 2.2500 |
Bid | 0.5500 |
Ask | 1.6500 |
Strike | 305.00 |
Expiry date | 2024-10-18 |
Day's range | 1.8600 - 2.2500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue by 27% in Q1, Provides Weak Outlook for FY ’24 The market […]
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...